Age-dependent differential regulation of genes encoding APP and alpha-synuclein in hippocampal synaptic plasticity

Hippocampus
A StéphanS Laroche

Abstract

We investigated the modulation of the messenger RNA encoding the amyloid precursor protein (APP) and alpha-synuclein following induction of long-term potentiation (LTP) in the dentate gyrus of young and aged rats. Three hours after tetanic stimulation, LTP induced in the young rats was maintained; the aged rats, however, fell into two subgroups: those in which LTP was maintained, and those in which LTP had declined to basal levels. In young rats, the global expression of mRNAs of all isoforms of APP and in particular that of the isoform lacking the KPI domain were significantly upregulated. In aged rats, the global expression of mRNAs of all isoforms of APP was not modified, regardless of whether LTP was maintained or not. The level of mRNA encoding the Kunitz protease-inhibitory (KPI)-minus isoform of APP, however, was increased in aged rats in which LTP was maintained, suggesting that the gene of this isoform may be more specifically regulated by synaptic plasticity. In contrast, we found that the gene encoding alpha-synuclein showed a trend towards being downregulated at the mRNA level in young rats following LTP, and significantly so in aged rats in which LTP was maintained, whereas it was not downregulated in aged rats wit...Continue Reading

References

Oct 1, 1991·Brain Research. Molecular Brain Research·L Maroteaux, R H Scheller
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G A HigginsF H Gage
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·M YoshimotoT Saitoh
Jul 25, 1994·FEBS Letters·L HesseG Multhaup
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·J M RochT Saitoh
May 23, 1994·FEBS Letters·R JakesM Goedert
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K UédaT Saitoh
Jan 7, 1993·Nature·T V Bliss, G L Collingridge
May 23, 1998·The Journal of Biological Chemistry·W S DavidsonJ M George
Oct 6, 1998·Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie·S Davis, S Laroche
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·H MezianeA Ungerer
Sep 6, 2000·The European Journal of Neuroscience·A R SahaV L Buchman
Dec 21, 2000·The European Journal of Neuroscience·R MileusnicS P Rose

❮ Previous
Next ❯

Citations

Feb 11, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Huajun JinAnumantha G Kanthasamy
May 28, 2013·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Andrea T U Schaefers, Gertraud Teuchert-Noodt
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Christophe WersingerAnita Sidhu
Apr 1, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anita SidhuPhilippe Vernier
Apr 23, 2016·Journal of Alzheimer's Disease : JAD·Anna PliássovaPaula Agostinho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.